Discontinued — last reported Q4 '20
An increase often reflects significant recent capital investments or acquisitions, while a stable or decreasing trend may suggest lower capital intensity or aging assets.
This metric represents the non-cash expense allocated to the Americas and global business segment for the wear and tear...
Comparable to segment-level depreciation and amortization charges reported by other capital-intensive medical device companies.
zbh_segment_americas_and_global_businesses_depreciation_and_amortization